PRESS RELEASE published on 12/17/2024 at 22:15, 1 year 10 months ago NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024 Nanobiotix announces virtual event 'Accelerating the Future of Nanotherapeutics' on December 19, 2024, showcasing Curadigm Nanoprimer Platform for drug development Virtual Event NANOBIOTIX Curadigm Nanotherapeutics Nanoprimer
PRESS RELEASE published on 12/17/2024 at 22:05, 1 year 10 months ago Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines Applied DNA Sciences, Inc. reports financial results for Q4 FY2024 and announces strategic restructuring with focus on genetic medicines. Completes GMP manufacturing facility by Jan 9, 2025 Financial Results Applied DNA Sciences Strategic Restructuring GMP Manufacturing Facility Genetic Medicines
PRESS RELEASE published on 12/17/2024 at 22:00, 1 year 10 months ago Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference » Inventiva annonce sa participation à la 43rd Annual J.P. Morgan Healthcare Conference. Frédéric Cren présentera les activités de la Société le 15 janvier 2025 à San Francisco Biopharmaceutique Inventiva MASH/NASH J.P. Morgan Healthcare Conference Frédéric Cren
PRESS RELEASE published on 12/17/2024 at 22:00, 1 year 10 months ago Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference with CEO Frédéric Cren providing a corporate overview and engaging in investor meetings Biopharmaceutical Inventiva J.P. Morgan Healthcare Conference Frédéric Cren Metabolic Dysfunction
PRESS RELEASE published on 12/17/2024 at 21:40, 1 year 10 months ago EQS-Adhoc: PIERER Mobility AG appoints Citigroup Global Markets Europe AG to reorganize its ownership structure PIERER Mobility AG appoints Citigroup Global Markets Europe AG to reorganize its ownership structure. Talks with potential investors ongoing Investors PIERER Mobility AG Cash Capital Increase Citigroup Global Markets Europe AG Ownership Structure
PRESS RELEASE published on 12/17/2024 at 21:30, 1 year 10 months ago PillSafe Founders' Interview Featured on Bloomberg, Fox Business, and Nasdaq Interview featuring Dr. John Barr and Jim Patton discussing PillSafe Technologies' role in securing prescriptions and fighting the opioid crisis. Founders share insights on innovative pill delivery system Medication Safety Prescription Compliance Opioid Crisis Smart Pill Delivery System PillSafe Technologies
PRESS RELEASE published on 12/17/2024 at 21:30, 1 year 10 months ago Sokoman Minerals Corp. Closes First Tranche of Non-Brokered Flow-Through and Hard-Dollar Private Placement Financing Sokoman Minerals Corp. announces conditional approval from TSX Venture Exchange for non-brokered Financing, issuing flow-through and non-flow-through shares, and paying cash finders' fees TSX Venture Exchange Financing Sokoman Minerals Corp. Flow-through Shares Finders' Fees
PRESS RELEASE published on 12/17/2024 at 20:40, 1 year 10 months ago Nuvau Minerals Starts Trading on TSXV Under Symbol NMC Nuvau Minerals Inc. announces the commencement of trading for its common shares and its focus on re-establishing Matagami mining district as a critical minerals producer. The company aims to restart production from the Bracemac McLeod mine and Caber complex Mining Exploration Nuvau Minerals Inc. Matagami Mining District Critical Minerals Producer Resource Base
PRESS RELEASE published on 12/17/2024 at 20:25, 1 year 10 months ago Kingfisher Announces Update to Private Placement Kingfisher Metals Corp. announces increase in non-brokered private placement to $1,750,000. Proceeds to fund business expansion and acquisition of Ball Creek West project Private Placement Business Expansion Kingfisher Metals Corp. Proceeds Ball Creek West Project
PRESS RELEASE published on 12/17/2024 at 20:00, 1 year 10 months ago PREDILIFE ANNONCE LA RÉALISATION D'UNE LEVÉE DE FONDS DE 779 000 EUROS DANS LE CADRE DE SON OFFRE AU PUBLIC D'OBLIGATIONS À 8,5% PAR AN REMBOURSABLES IN FINE EN INTEGRALITÉ EN ESPÈCES OU EN ACTIONS Predilife annonce une levée de fonds de 779 000 euros via une offre d'obligations remboursables en espèces ou en actions. Objectifs: financement des activités jusqu'en 2025, renforcement de partenariats industriels Obligations Levée De Fonds Offre Publique PREDILIFE Partenariats Industriels
Published on 11/02/2026 at 13:00, 21 minutes ago International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
Published on 11/02/2026 at 13:00, 21 minutes ago Bocana Resources Corp. provides an Update on the Proposed Transaction with London Gold LLC
Published on 11/02/2026 at 13:00, 21 minutes ago Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
Published on 11/02/2026 at 12:30, 51 minutes ago Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
Published on 11/02/2026 at 12:10, 1 hour 11 minutes ago Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
Published on 11/02/2026 at 13:17, 4 minutes ago Westpac 2026 Full Year Financial Results Announcement
Published on 11/02/2026 at 12:45, 36 minutes ago Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial
Published on 11/02/2026 at 08:40, 4 hours 40 minutes ago Octobre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 10/30/2026 at 23:00, 2 days 14 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 2 days 14 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie